HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA Targets DermaTox Maker In Year’s First Published Warnings To Cosmetics Firms

This article was originally published in The Rose Sheet

Executive Summary

Healthy Habits reacts indignantly to FDA’s warning about testimonials for DermaTox products featured on its website, which the agency says identify the items as unapproved drugs. Aegeia Skin Care also receives a warning letter for structure/function and disease-treatment claims on its facial- and body-care products.


Related Content

FDA's Online Surveillance Continues With Warning Letter To Blissoma
Soap Maker Warned As FDA's Cosmetics Enforcement Activity Picks Up
FDA Puts Kibosh On Perfectly Posh For Unapproved Drug Claims
NSF International Launches Cosmetic Verification Program For ‘Consumer Assurance’
FDA Clampdown On Excessive Anti-Aging Claims May Lighten Up In 2017
FDA: Cosmetic Warning Letters Carry Same Weight Regardless Of Issuing Office





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts